Filtered By:
Cancer: Primary CNS Lymphoma
This page shows you your search results in order of date.
Order by Relevance | Date
Total 41 results found since Jan 2013.
Contribution of nuclear medicine to the diagnosis and management of primary brain tumours
Rev Neurol (Paris). 2023 Mar 16:S0035-3787(23)00874-3. doi: 10.1016/j.neurol.2023.03.002. Online ahead of print.ABSTRACTPositron emission tomography (PET) is a powerful tool that can help physicians manage primary brain tumours at diagnosis and follow-up. In this context, PET imaging is used with three main types of radiotracers: 18F-FDG, amino acid radiotracers, and 68Ga conjugated to somatostatin receptor ligands (SSTRs). At initial diagnosis, 18F-FDG helps to characterize primary central nervous system (PCNS) lymphomas and high-grade gliomas, amino acid radiotracers are indicated for gliomas, and SSTR PET ligands are in...
Source: Revue Neurologique - March 18, 2023 Category: Neurology Authors: T Horowitz E Tabouret T Graillon B Salgues O Chinot A Verger E Guedj Source Type: research
Clinical utility of serum glial fibrillary acidic protein in glial neoplasm
CONCLUSION: Increasing serum GFAP levels in the preoperative period correlate with higher tumor grade, especially grade III and grade IV tumors. The serum GFAP levels showed relation to tumor volume, both before and after surgery.PMID:36761257 | PMC:PMC9899464 | DOI:10.25259/SNI_889_2022
Source: Surgical Neurology International - February 10, 2023 Category: Neurosurgery Authors: Nidhi Yadav Keshav Mishra Anil Kumar B C Daljit Singh Manju Subberwal Source Type: research
